| Literature DB >> 15350527 |
Patrick Rossignol1, Marie-Christine Bouton, Martine Jandrot-Perrus, Marijke Bryckaert, Marie-Paule Jacob, Annie Bezeaud, Marie-Claude Guillin, Jean-Baptiste Michel, Olivier Meilhac.
Abstract
Whereas thrombin (below 10 nM) is a potent mitogen, recent studies report that exposure to higher doses of thrombin could lead to apoptosis of neurons and tumor cells. Our results show that prolonged exposure (> or = 24 h) to thrombin (50-100 nM) exerts a pro-apoptotic effect on cultured vascular smooth muscle cells (VSMCs). This phenomenon depends on thrombin serine-protease activity but is independent of PAR-1 and -4 activation and subsequent signaling. The parallel occurrence of cell retraction and cleavage of fibronectin suggests that thrombin-induced apoptosis is consecutive to pericellular proteolysis. These data point to a new potential action of thrombin in the cardiovascular system. Copyright 2004 Elsevier Inc.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15350527 DOI: 10.1016/j.yexcr.2004.05.034
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905